RTW INVESTMENTS, LP Q1 2022 Filing
Filed May 16, 2022
Portfolio Value
$4.8B
Holdings
106
Report Date
Q1 2022
Filing Type
13F-HR
All Holdings (106 positions)
| Stock | Value |
|---|---|
ALNYALNYLAM PHARMACEUTICALS INC | $274.9M |
RCKTROCKET PHARMACEUTICALS INC | $250.6M |
TMOTHERMO FISHER SCIENTIFIC INC | $220.3M |
PTCTPTC THERAPEUTICS INC | $194.8M |
ILMNILLUMINA INC | $178.0M |
3M4MASIMO CORP | $164.1M |
ESTAESTABLISHMENT LABS HLDGS INC | $156.3M |
VCELVERICEL CORP | $153.6M |
PENPENUMBRA INC | $147.9M |
MRTXEURMIRATI THERAPEUTICS INC | $128.4M |
GMEDGLOBUS MED INC | $124.1M |
TNDMTANDEM DIABETES CARE INC | $116.9M |
PTGXPROTAGONIST THERAPEUTICS INC | $113.5M |
CCCCC4 THERAPEUTICS INC | $109.9M |
AXNX*AXONICS INC | $109.2M |
ARGXARGENX SE | $106.3M |
CUTREURCUTERA INC | $105.3M |
TCE2CELLDEX THERAPEUTICS INC NEW | $105.0M |
—PROMETHEUS BIOSCIENCES INC | $104.1M |
RAREULTRAGENYX PHARMACEUTICAL IN | $99.7M |
CYTKCYTOKINETICS INC | $94.3M |
RNAAVIDITY BIOSCIENCES INC | $88.6M |
FULCFULCRUM THERAPEUTICS INC | $85.4M |
PMVPPMV PHARMACEUTICALS INC | $80.6M |
NTRANATERA INC | $78.0M |
STOKSTOKE THERAPEUTICS INC | $76.7M |
RLMDRELMADA THERAPEUTICS INC | $68.6M |
AXSMAXSOME THERAPEUTICS INC | $67.0M |
RGNXREGENXBIO INC | $61.2M |
TORCEURADICET BIO INC | $59.7M |
BCYCBICYCLE THERAPEUTICS PLC | $56.0M |
TXG10X GENOMICS INC | $55.9M |
IMCRIMMUNOCORE HLDGS PLC | $55.6M |
DMTKQDERMTECH INC | $45.8M |
GHGUARDANT HEALTH INC | $45.7M |
OMGBPOUTSET MED INC | $40.8M |
GHRSGH RESEARCH PLC | $39.7M |
AVDLAVADEL PHARMACEUTICALS PLC | $39.2M |
QTRXQUANTERIX CORP | $36.4M |
MGNXMACROGENICS INC | $35.0M |
TARSTARSUS PHARMACEUTICALS INC | $33.9M |
JNCEEURJOUNCE THERAPEUTICS INC | $31.8M |
IMUXIMMUNIC INC | $30.6M |
TNYATENAYA THERAPEUTICS INC | $29.0M |
MISTMILESTONE PHARMACEUTICALS IN | $27.7M |
—ATHIRA PHARMA INC | $25.7M |
—CINCOR PHARMA INC | $24.4M |
OYSTOYSTER PT PHARMA INC | $24.0M |
CSTLCASTLE BIOSCIENCES INC | $22.3M |
APYXAPYX MEDICAL CORPORATION | $22.2M |
—SCIENCE 37 HOLDINGS INC | $21.6M |
VTYXVENTYX BIOSCIENCES INC | $21.1M |
TSVT*2SEVENTY BIO INC | $21.0M |
LUNGPULMONX CORP | $19.8M |
—OLINK HLDG AB | $18.0M |
GLUEMONTE ROSA THERAPEUTICS INC | $17.0M |
EPIEURESSA PHARMA INC | $16.3M |
5E7ITEOS THERAPEUTICS INC | $15.7M |
CTMXCYTOMX THERAPEUTICS INC | $15.4M |
NSTGEURNANOSTRING TECHNOLOGIES INC | $14.0M |
BWAYBRAINSWAY LTD | $14.0M |
WHWKAADI BIOSCIENCES INC | $13.0M |
—RENOVACOR INC | $12.7M |
TELATELA BIO INC | $11.8M |
SGHTSIGHT SCIENCES INC | $11.5M |
—LA JOLLA PHARMACEUTICAL CO | $9.9M |
AGENEURAGENUS INC | $8.8M |
PYXSPYXIS ONCOLOGY INC | $8.6M |
XGNEXAGEN INC | $8.0M |
URGNUROGEN PHARMA LTD | $7.5M |
NYXHNYXOAH S A | $6.6M |
PRQRPROQR THRAPEUTICS N V | $6.4M |
—LANDOS BIOPHARMA INC | $6.3M |
—RESEARCH ALLIANCE CORP II | $6.2M |
—BCLS ACQUISITION CORP | $6.0M |
PRCTPROCEPT BIOROBOTICS CORP | $5.6M |
—ARYA SCIENCES ACQU CORP IV | $4.9M |
—SUMMIT HEALTHCRE ACQUISTN CO | $4.9M |
—ARYA SCIENCES ACQUISITN CORP | $4.9M |
NAUTNAUTILUS BIOTECHNOLOGY INC | $4.8M |
ROIVROIVANT SCIENCES LTD | $4.0M |
—POINT BIOPHARMA GLOBAL INC | $3.9M |
—5 01 ACQUISITION CORP | $3.9M |
JNJJOHNSON & JOHNSON | $3.2M |
—MEDICUS SCIENCES ACQUISITION | $2.9M |
—ASLAN PHARMACEUTICALS LTD | $2.9M |
IMTXIMMATICS N.V | $2.8M |
—GENETRON HLDGS LTD | $2.6M |
APLSAPELLIS PHARMACEUTICALS INC | $2.6M |
RXSTRXSIGHT INC | $1.9M |
SOPHSOPHIA GENETICS SA | $1.8M |
—APOLLO ENDOSURGERY INC | $1.6M |
MXCTGBXMAXCYTE INC | $1.4M |
CNTBCONNECT BIOPHARMA HLDGS LTD | $1.3M |
—ISOPLEXIS CORP | $1.3M |
—MIROMATRIX MED INC | $1.1M |
DNAYCODEX DNA INC | $1.1M |
RCELAVITA MEDICAL INC | $905K |
—AKOYA BIOSCIENCES INC | $854K |
MASS908 DEVICES INC | $760K |
Page 1 of 2Next